Page last updated: 2024-09-03

5-bromo-2',3'-dideoxyuridine and 2,6-diaminopurine 2',3'-dideoxyriboside

5-bromo-2',3'-dideoxyuridine has been researched along with 2,6-diaminopurine 2',3'-dideoxyriboside in 1 studies

Compound Research Comparison

Studies
(5-bromo-2',3'-dideoxyuridine)
Trials
(5-bromo-2',3'-dideoxyuridine)
Recent Studies (post-2010)
(5-bromo-2',3'-dideoxyuridine)
Studies
(2,6-diaminopurine 2',3'-dideoxyriboside)
Trials
(2,6-diaminopurine 2',3'-dideoxyriboside)
Recent Studies (post-2010) (2,6-diaminopurine 2',3'-dideoxyriboside)
8011100

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Agrawal, B; Johar, M; Kumar, R; Kunimoto, DY; Manning, T; Rai, D; Srivastav, NC1

Other Studies

1 other study(ies) available for 5-bromo-2',3'-dideoxyuridine and 2,6-diaminopurine 2',3'-dideoxyriboside

ArticleYear
Inhibition of Mycobacterium tuberculosis, Mycobacterium bovis, and Mycobacterium avium by novel dideoxy nucleosides.
    Journal of medicinal chemistry, 2007, Sep-20, Volume: 50, Issue:19

    Topics: Adenosine; Alkynes; Animals; Anti-Bacterial Agents; Cell Line; Cell Survival; Dideoxynucleosides; Drug Resistance, Bacterial; Guanosine; Microbial Sensitivity Tests; Mycobacterium avium; Mycobacterium bovis; Mycobacterium tuberculosis; Purine Nucleosides; Structure-Activity Relationship; Uridine

2007